Stopping anticoagulation for isolated or incidental pulmonary embolism: the STOPAPE RCT protocol

Autor: Daniel Lasserson, Pooja Gaddu, Samir Mehta, Agnieszka Ignatowicz, Sheila Greenfield, Clare Prince, Carole Cummins, Graham Robinson, Jonathan Rodrigues, Simon Noble, Sue Jowett, Mark Toshner, Michael Newnham, Alice Turner

Publikováno v: Health Technology Assessment (2024)

Research question Is withholding anticoagulation for patients with isolated or incidental subsegmental pulmonary embolism clinically and cost-effective compared with full anticoagulation for 3 months? Background There has been an increase in the diag

Externí odkaz: https://doaj.org/article/66e86b173be14823b6cfe740e88a769e

Stopping anticoagulation for isolated or incidental pulmonary embolism: the STOPAPE RCT protocol.

Autor: Lasserson D; Health Sciences Division, University of Warwick, Coventry, UK., Gaddu P; Clinical Trials Unit, University of Birmingham, Birmingham, UK., Mehta S; Clinical Trials Unit, University of Birmingham, Birmingham, UK., Ignatowicz A; Institute of Applied Health Research, University of Birmingham, Birmingham, UK., Greenfield S; Institute of Applied Health Research, University of Birmingham, Birmingham, UK., Prince C; Thrombosis UK, Wales, UK., Cummins C; Institute of Applied Health Research, University of Birmingham, Birmingham, UK., Robinson G; Royal United Hospitals Bath NHS Foundation Trust, Bath, UK., Rodrigues J; Royal United Hospitals Bath NHS Foundation Trust, Bath, UK., Noble S; University of Cardiff, Cardiff, UK., Jowett S; Institute of Applied Health Research, University of Birmingham, Birmingham, UK., Toshner M; University of Cambridge, Cambridge, UK., Newnham M; Institute of Applied Health Research, University of Birmingham, Birmingham, UK., Turner A; Institute of Applied Health Research, University of Birmingham, Birmingham, UK.

Publikováno v: Health technology assessment (Winchester, England) [Health Technol Assess] 2024 Jun 26, pp. 1-17. Date of Electronic Publication: 2024 Jun 26.